Cyclacel
Investors & Media

News

All Releases
View Summary Cyclacel Pharmaceuticals to present at the Atlas Venture Japan Biopharma Partnering Conference 2007
Mar 14, 2007
PDF 10.8 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to present at Cowen and Company 27th Annual Health Care Conference
Mar 8, 2007
PDF 11.4 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to announce fourth quarter and year-end 2006 financial results on March 15, 2007
Mar 5, 2007
PDF 11.9 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals completes $36 million registered direct financing
Feb 20, 2007
PDF 10.9 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals announces $36 million registered direct financing
Feb 13, 2007
PDF 12.4 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to present at 2007 Bio CEO & Investor Conference
Feb 7, 2007
PDF 11.4 KB Add to Briefcase
View Summary Cyclacel announces development plan for its seliciclib CDK inhibitor to treat nasopharyngeal cancer
Feb 5, 2007
PDF 13.5 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals, Inc. announces quarterly dividends for 6% convertible exchangeable preferred stock
Jan 30, 2007
PDF 11.0 KB Add to Briefcase
View Summary Cyclacel submits IND of CYC116 an Aurora kinase and VEGRF2 inhibitor to treat cancer
Dec 13, 2006
PDF 12.5 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to present at NYSSA 10th annual Biotech/Speciality Pharma Industry Conference
Dec 6, 2006
PDF 11.8 KB Add to Briefcase
View Summary Cyclacel reports interim Phase I data for sapacitabine in patients with advanced leukemias or myelodysplastic syndromes
Nov 28, 2006
PDF 14.4 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to present at Lazard Capital Markets Life Sciences Conference
Nov 17, 2006
PDF 11.2 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals reports third quarter 2006 financial results
Nov 13, 2006
PDF 15.8 KB Add to Briefcase
View Summary Cyclacel reports Phase I sapacitabine study results at 18th EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics meeting
Nov 10, 2006
PDF 13.5 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to announce third quarter 2006 financial results on November 13, 2006
Nov 6, 2006
PDF 11.9 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to present at Rodman & Renshaw annual healthcare conference
Oct 30, 2006
PDF 12.1 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to present at C.E. Unterberg, Towbin Emerging Opportunities in Healthcare Conference
Oct 24, 2006
PDF 11.3 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals names John Womelsdorf, Ph.D., Vice President, Business Development
Oct 24, 2006
PDF 12.8 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals, Inc. announces quarterly dividend for 6% Convertible Exchangeable Preferred Stock
Oct 23, 2006
PDF 10.9 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to present at Thomson Financial and Biocentury's: NewsMakers in the Biotech Industry Conference
Sep 5, 2006
PDF 11.5 KB Add to Briefcase
Showing 321-340 of 354 Page: 1 ... 13 14 15 16 17 18  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase
Investors & Media